Peptides are short linear strings of amino acids that control many functions in the human body, normally not organized in a stable three-dimensional structure, at least before their binding to targets. The length limit between a peptide and a protein is arbitrarily fixed as 50 amino acids and molecular weight below 10 kDa. Currently, peptide-based therapeutics are experiencing a renaissance in the global market with collective sales of more than US$ 20 Billion in 2017. In general, the global peptide therapeutics market is expected to surpass US$ 50 Billion before 2024. The whole market growth will be driven by the increasing research and development expenditure by pharmaceutical organizations along with rapid entry of multiple peptide-based drug in the market. CD BioSciences provides in-depth peptides trial knowledge spans the entire clinical process, from the design and execution of proof-of-concept trials to submissions and regulatory approval.